Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda
PHASE3CompletedINTERVENTIONAL
Enrollment
155
Participants
Timeline
Start Date
August 21, 2002
Primary Completion Date
February 1, 2008
Study Completion Date
February 1, 2008
Conditions
HIV
Interventions
DRUG
HAART
Trial Locations (1)
Unknown
Joint Clinical Research Center, Kampala
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00339456 - Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda | Biotech Hunter | Biotech Hunter